Table 3.
Assessment of Efficacy
| Time Interval | Clinical Examination |
|---|---|
| At Baseline | Body Mass Index (BMI) |
| Free testosterone (pg/ml) | |
| Total testosterone (ng/dl) | |
| DHEA-S levels | |
| Fasting blood sugar (FBS) | |
| Fasting lipid profile (total cholesterol, LDL, HDL, triglycerides, VLDL) | |
| Liver function tests (AST, ALT, ALP) | |
| Hemogram | |
| Semen examination (sperm count, sperm motility, sperm morphology | |
| At the End of 4- and 8 Weeks | BMI (Kg/m2) |
| Fasting lipid profile (total cholesterol, LDL, HDL, triglycerides, VLDL) | |
| Semen examination (sperm count, sperm mobility, sperm morphology | |
| End of Study (12 Weeks) | BMI |
| Free testosterone (pg/ml) | |
| Total testosterone (ng/dl) | |
| DHEA-S levels | |
| Fasting blood sugar (FBS) | |
| Fasting lipid profile (total cholesterol, LDL, HDL, triglycerides, VLDL) | |
| Liver function tests (AST, ALT, ALP) | |
| Hemogram | |
| Semen examination (sperm count, sperm mobility, sperm morphology |